AU2003240730A1 - Morpholinylmethylureas ccr-3 receptor antagonist - Google Patents

Morpholinylmethylureas ccr-3 receptor antagonist

Info

Publication number: AU2003240730A1
Authority: AU; Australia
Prior art keywords: morpholinylmethylureas; ccr; receptor antagonist; antagonist; receptor
Prior art date: 2002-05-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003240730A

Inventor

Caroline Mary Cook

Colin David Eldred

Lee Andrew Harrison

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2003-05-26

Publication date

2003-12-12

2003-05-26 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-12-12 Publication of AU2003240730A1 publication Critical patent/AU2003240730A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003240730A 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist Abandoned AU2003240730A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0212357.8A GB0212357D0 (en)	2002-05-29	2002-05-29	Novel compounds
GB0212357.8		2002-05-29
PCT/EP2003/005597 WO2003099798A1 (en)	2002-05-29	2003-05-26	Morpholinylmethylureas ccr-3 receptor antagonist

Publications (1)

Publication Number	Publication Date
AU2003240730A1 true AU2003240730A1 (en)	2003-12-12

Family

ID=9937626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003240730A Abandoned AU2003240730A1 (en)	2002-05-29	2003-05-26	Morpholinylmethylureas ccr-3 receptor antagonist

Country Status (3)

Country	Link
AU (1)	AU2003240730A1 (en)
GB (1)	GB0212357D0 (en)
WO (1)	WO2003099798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1801108T3 (en)	2004-09-08	2013-02-18	Mitsubishi Tanabe Pharma Corp	Morpholine compounds for the treatment of inflammation.
EP3050574B1 (en)	2015-01-28	2019-10-09	Universite De Bordeaux	Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69527786T2 (en) *	1994-05-18	2003-04-10	Nisshin Seifun Group Inc., Tokio/Tokyo	DIAMINOMETHYLIDEN DERIVATIVES
EP1187810A2 (en) *	1999-05-25	2002-03-20	Sepracor, Inc.	Heterocyclic analgesic compounds and their use
HUP0303107A2 (en) *	2000-09-29	2004-03-01	Glaxo Group Ltd.	Compounds useful in the treatment of inflammatory diseases, process for their preparation and pharmaceutical compositions containing them
ES2527688T3 (en) *	2000-09-29	2015-01-28	Glaxo Group Limited	Morpholin-acetamide derivatives for the treatment of inflammatory diseases

2002
- 2002-05-29 GB GBGB0212357.8A patent/GB0212357D0/en not_active Ceased
2003
- 2003-05-26 WO PCT/EP2003/005597 patent/WO2003099798A1/en not_active Ceased
- 2003-05-26 AU AU2003240730A patent/AU2003240730A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003099798A8 (en)	2004-01-15
WO2003099798A1 (en)	2003-12-04
GB0212357D0 (en)	2002-07-10

Similar Documents

Publication	Publication Date	Title
AU2003231513A1 (en)	2003-12-02	Pgd2 receptor antagonist
AU2003261392A1 (en)	2004-02-23	M3muscarinic acetylcholine receptor antagonists
SI2065384T1 (en)	2011-05-31	Tricyclic thrombin receptor antagonist
AU2003241836A1 (en)	2004-04-23	Lpa receptor antagonists
EP1576112A3 (en)	2005-09-01	Cytokine receptor zcytor17 multimers
IL165841A0 (en)	2006-01-15	Mchir antagonists
AUPR833401A0 (en)	2001-11-08	G protein-coupled receptor antagonists
AU2003301851A1 (en)	2004-06-07	Azacyclic compounds as orexin receptor antagonist
AU2003255501A1 (en)	2004-04-30	Cxcr4 receptor antagonists
PL378753A1 (en)	2006-05-15	Ccr-3 receptor antagonists
AU2003291959A1 (en)	2004-07-14	Novel glucagon antagonists
IL164016A0 (en)	2005-12-18	Azetidine derivatives as ccr-3 receptor antagonists
IL165727A0 (en)	2006-01-15	Chemokine antagonists
AU2003267088A1 (en)	2004-04-30	Chemokine receptor antagonists as therapeutic agents
AU2003236247A1 (en)	2003-11-17	Bombesin antagonists
AU2003240705A1 (en)	2003-12-02	Morpholinylmethylureas ccr-3 receptor antagonists
AU2003248356A1 (en)	2003-09-09	Beta3-adrenergic receptor agonists
AU2003242506A1 (en)	2004-02-02	Tf antagonist
AU2003300904A1 (en)	2004-07-09	Antagonists for human prolactin
AU2003287219A1 (en)	2004-05-25	Il-8 receptor antagonists
PL370367A1 (en)	2005-05-16	Ccr-3 receptor antagonists v
PL373275A1 (en)	2005-08-22	Ccr-3 receptor antagonists vii
AU2003240730A1 (en)	2003-12-12	Morpholinylmethylureas ccr-3 receptor antagonist
AU2003242244A1 (en)	2003-12-22	Chemokine receptor antagonist
GB0215389D0 (en)	2002-08-14	Receptor

Legal Events

Date	Code	Title	Description
2005-02-24	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase